Reply to the letter by Takeshi Yamada et al. concerning “Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?”
Crossref DOI link: https://doi.org/10.1007/s00535-016-1185-1
Published Online: 2016-02-20
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Jun
Peng, Zhi
Shen, Lin
Text and Data Mining valid from 2016-02-20